Microsoft develops AI doctor tool and BMO lifts target for Microsoft stock

Published on 10/23/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BMO sets a USD 600 target from USD 515 on October 20, 2026. Microsoft stock costs EUR 462.35 on October 23, 2026 before results on October 28.

Health AI and valuation

Reuters reported on October 22, 2026 that Microsoft's diagnostic AI was more than twice as accurate as general physicians in complex cases.
BMO Capital raised its Microsoft target from USD 515.00 to USD 600.00 on October 20, 2026.
Microsoft stock trades at EUR 462.35 at 11:01 a.m. CEST at Lang & Schwarz on October 23, 2026.
Microsoft's fiscal first-quarter results are scheduled for October 28, 2026.

Extreme macro photograph of a single wide mechanical keyboard keycap partially removed, revealing gold spring and translucent switch housing with blue backlight glow, surrounding keys in soft bokeh, high contrast studio lighting — Microsoft Corporation (US5949181045) Makro: Detail einer mechanischen Tastatur-Taste mit Federn und blauem Backlight, Illustration mit AI erstellt.

Microsoft Corporation (ISIN US5949181045) was trading at EUR 462.35 at Lang & Schwarz on October 23, 2026 at 11:01 a.m. CEST. Reuters reported on October 22, 2026 that Microsoft researchers developed an AI diagnostic tool that was more than twice as accurate as general physicians in complex cases.

Three dated catalysts shape the setup

On July 29, 2026, Microsoft reported quarterly revenue of USD 90.01 billion, up 17.70 percent year over year, while adjusted earnings per share reached USD 4.74. MarketBeat said the quarter exceeded consensus revenue of USD 87.62 billion and adjusted earnings per share of USD 4.24.

On October 20, 2026, MarketScreener reported that BMO Capital raised its Microsoft price target from USD 515.00 to USD 600.00. The current event came on October 22, 2026, when Reuters described the health AI model's performance across more than 300 unusual medical cases.

What is the next earnings test?

Microsoft's next measurable test is its fiscal first-quarter 2027 report, scheduled for October 28, 2026, after the market close. The date appears on Microsoft Investor Relations. That report will give investors a fresh comparison with the USD 90.01 billion quarterly revenue base and the 17.70 percent growth rate reported for the June quarter.

Dates and valuation signals

The next reporting date is October 28, 2026, for fiscal first-quarter results. Microsoft also published its fiscal 2026 annual report after revenue reached USD 331.84 billion for the year ended June 30, 2026, according to standardized financial figures.

Stock context before results

Microsoft's Nasdaq quote was last at USD 521.08 on October 22, 2026 at 4:00 p.m. EDT. The same market snapshot placed the 52-week range at USD 349.20 to USD 553.72 and market capitalization at USD 3.9 trillion. The euro quote serves a different investor perspective, so the two currencies are kept separate rather than combined into one performance figure.

Microsoft's health AI research adds a concrete product signal before the earnings date, while the BMO target shows how analysts are framing Azure and artificial intelligence expectations. The earnings release will test whether the June-quarter growth rate can continue alongside the company's large infrastructure commitments.

Microsoft stock before the report

Microsoft was trading at EUR 462.35 at Lang & Schwarz on October 23, 2026 at 11:01 a.m. CEST. On Nasdaq, the stock was last at USD 521.08 on October 22, 2026 at 4:00 p.m. EDT. The further course of trading is shown by the continuously updated real-time quote of Microsoft stock.